Clinical Trials Logo

Clinical Trial Summary

The measurement of dynamic arterial elastance (Eadyn) was proposed as a marker of vascular tone. It is calculated by the ratio of the respiratory variation of the pulse pressure and the respiratory variation of stroke volume. Despite several clinical studies, no study has really focused on the physiological significance of Eadyn. No study demonstrates at present, if this index is a reflect of macrocirculatory parameters (systemic resistances, blood pressure, arterial elastance, ventricular elastance, ventriculo-arterial coupling) or microcirculatory tone in the capillaries and small arterioles (critical capillary pressure or capillary resistance). the physicians don't know which variables are associated with this index. the hypothesis is that Eadyn is an indirect reflect of capillary pressure (PCC).


Clinical Trial Description

The measurement of dynamic arterial elastance (Eadyn) was proposed as a marker of vascular tone. It is calculated by the ratio of the respiratory variation of the pulse pressure and the respiratory variation of stroke volume. Despite several clinical studies, no study has really focused on the physiological significance of Eadyn. No study demonstrates at present, if this index is a reflect of macrocirculatory parameters (systemic resistances, blood pressure, arterial elastance, ventricular elastance, ventriculo-arterial coupling) or microcirculatory tone in the capillaries and small arterioles (critical capillary pressure or capillary resistance). the physicians don't know which variables are associated with this index. One hypothesis is that Eadyn is an indirect reflection of capillary pressure (PCC). The main objective of this project is to study the correlation between the measure of Eadyn and the PCC. The study begins when the physician in charge of the patient decides a hemodynamic treatment (either volume expansion or norepinephrine). The indication of the treatment is left to the discretion of the physician in charge of the patient: volume expansion or vasopressor agent. After verification of inclusion criteria, the physician collects demographic, ventilatory, hemodynamic, cardiac ultrasound data, and the type of treatment initiated (volume expansion, norepinephrine, and their dosages). 15 minutes after the introduction of the therapy and stabilization of the hemodynamic state, a new series of measurements of the aforementioned. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03478709
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact Pierre-Grégoire Guinot, Doctor
Phone +333 22 08 78 99
Email guinot.pierregregoire@chu-amiens.fr
Status Recruiting
Phase
Start date October 22, 2017
Completion date April 22, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04511234 - Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease N/A
Completed NCT04359446 - Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent N/A
Completed NCT04285411 - Vital USA SpO2 Accuracy Comparison to Arterial Blood CO-Oximetry N/A
Not yet recruiting NCT05554055 - Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
Completed NCT04651894 - Relationship Between Digital Vascular Function Measured by EndoPAT® in elderlY Patients and Arterial Stiffness
Active, not recruiting NCT04061798 - ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair. Phase 4
Recruiting NCT04428138 - Inguinal Hernia and Arterial Disease
Withdrawn NCT01570803 - Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease N/A
Active, not recruiting NCT03970538 - PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia N/A
Recruiting NCT03426293 - Measuring the ACT During Non-cardiac Arterial Procedures.
Recruiting NCT04258046 - Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation Phase 2
Recruiting NCT05054764 - Promus PREMIER Below The Knee Registry